Efficacy and safety of sunitinib in previously treated, advanced non-small cell lung cancer (NSCLC): Preliminary results of a multicenter phase II trial.

被引：0
|
作者：
Socinski, M. A.
Novello, S.
Sanchez, J. M.
Brahmer, J. A.
Govindan, R.
Belani, C. P.
Atkins, J. N.
Gillenwater, H. H.
Palleres, C.
Chao, R. C.
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Univ Turin, I-10124 Turin, Italy
[3] Hosp Germans Trias & Pujol, Barcelona, Spain
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Washington Univ, Sch Med, St Louis, MO USA
[6] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA
[7] SE Med Oncol, Goldsboro, NC USA
[8] Univ Virginia, Charlottesville, VA USA
[9] Hosp San Pablo, Barcelona, Spain
[10] Pfizer, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：364S / 364S
页数：1
相关论文
共 50 条
  • [21] A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
    Gerena-Lewis, Margie
    Crawford, Jeffrey
    Bonomi, Philip
    Maddox, Ann Marie
    Hainsworth, John
    McCune, David E.
    Shukla, Rakesh
    Zeigler, Haoyue
    Hurtubise, Paul
    Chowdhury, Tracy R.
    Fletcher, Brandon
    Dyehouse, Karyn
    Ghalie, Richard
    Jazieh, Abdul R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 269 - 273
  • [22] EFFICACY AND SAFETY OF CRIZOTINIB IN ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) RESULTS FROM A PHASE II GLOBAL TRIAL
    Ferreira, Carlos G.
    Barrios, C.
    Shaw, Alice T.
    Shi, Yuankai
    De Pas, Tommaso M.
    Yang, Pan C.
    Riely, Greg J.
    Crino, Lucio
    Iyer, Shrividya
    Polli, Anna
    Lanzalone, Silvana
    Kim, Dong W.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S107 - S108
  • [23] Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
    S Novello
    G V Scagliotti
    R Rosell
    M A Socinski
    J Brahmer
    J Atkins
    C Pallares
    R Burgess
    L Tye
    P Selaru
    E Wang
    R Chao
    R Govindan
    British Journal of Cancer, 2009, 101 : 1543 - 1548
  • [24] Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer
    Novello, S.
    Scagliotti, G. V.
    Rosell, R.
    Socinski, M. A.
    Brahmer, J.
    Atkins, J.
    Pallares, C.
    Burgess, R.
    Tye, L.
    Selaru, P.
    Wang, E.
    Chao, R.
    Govindan, R.
    BRITISH JOURNAL OF CANCER, 2009, 101 (09) : 1543 - 1548
  • [25] Pralatrexate with Vitamin Supplementation in Patients with Previously Treated, Advanced Non-small Cell Lung Cancer Safety and Efficacy in a Phase 1 Trial
    Azzoli, Christopher G.
    Patel, Jyoti D.
    Krug, Lee M.
    Miller, Vincent
    James, Leonard
    Kris, Mark G.
    Ginsberg, Michelle
    Subzwari, Sara
    Tyson, Leslie
    Dunne, Megan
    May, Jennifer
    Huntington, Martha
    Saunders, Michael
    Sirotnak, F. M.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1915 - 1922
  • [26] Phase II pharmacodynamic trial of erlotinib in previously treated patients with advanced non-small-cell lung cancer (NSCLC):: Study results
    Felip, Enriqueta
    Rojo, Frederico
    Reck, Martin
    Heller, Astrid
    Klughammer, Barbara
    Maacke, Heiko
    Mocks, Joachim
    Brennscheidt, Ulrich
    Gatzemeier, Ulrich
    Baselga, Jose
    ANNALS OF ONCOLOGY, 2006, 17 : 235 - 235
  • [27] Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Anish B. Parikh
    Peter Kozuch
    Nicholas Rohs
    Daniel J. Becker
    Benjamin P. Levy
    Investigational New Drugs, 2017, 35 : 813 - 819
  • [28] Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial
    Parikh, Anish B.
    Kozuch, Peter
    Rohs, Nicholas
    Becker, Daniel J.
    Levy, Benjamin P.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 813 - 819
  • [29] ERLOTINIB AND BEXAROTENE FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Dragnev, K. H.
    Seltzer, M.
    Rigas, J. R.
    DiSalvo, W. M.
    Simeone, S.
    Johnstone, D.
    Nugent, W.
    Waxman, S.
    Dmitrovsky, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [30] Docetaxel (D) and vinorelbine (V) in non-small cell lung cancer (NSCLC) previously treated with cisplatin-based chemotherapy:: A phase II trial.
    Muñoz, A
    Rubio, I
    Mañé, JM
    Ferreiro, J
    Fernández, R
    Fuente, N
    Abón, G
    López-Argumedo, G
    Barceló, R
    Vivanco, GL
    ANNALS OF ONCOLOGY, 2000, 11 : 117 - 117
12345